PhoenixMD selected to participate in the Outsourced Pharma Event (August 21-22, 2018) in San Diego, California

Outsourced Pharma.png

May 24, 2018 - In this all San Diego panel of three companies, Sandra Dunn, founder and CEO of Phoenix Molecular Designs, and members of her senior leadership team will present a detailed case study and insight into her virtual biotechnology company’s working relationship with CDMO WuXi (San Diego operations) and toxicology service provider Paracelsus, Inc. on August 22, 2018.

For the complete agenda for this session “Navigating an Ocean of Drug Development & Manufacturing Outsourcing” click here